Please do not leave this page until complete. This can take a few moments.
Rocky Hill-based medical technology firm Lumeda, which is developing a lung cancer-killing light therapy system, raised $4.3 million through its Series A funding round and now expects to start human clinical studies by the middle of this year, company officials announced Thursday.
Combined with a seed funding round that took place early last year, Lumeda has raised $5.3 million to date, they said.
The Series A round was led by Connecticut Innovations, the state’s venture investment arm, with participation from Cycle Venture Partners, a Branford-based venture capital group.
The company expects two first-in-human clinical studies to commence at Roswell Park Comprehensive Cancer Center in Buffalo, New York, by mid-2021, and CEO Sandy Zinke said the plan is to “expand testing to other sites in the U.S., Europe and Japan.”
Lumeda’s technology, branded as DigiLum, is a form of photodynamic therapy, which involves introducing a photosensitizer drug to cancer cells that triggers cell death upon light activation.
The Hartford Business Journal 2025 Charity Event Guide is the annual resource publication highlighting the top charity events in 2025.
Learn moreHartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
SubscribeDelivering vital marketplace content and context to senior decision-makers throughout Connecticut ...
All Year Long!
The Hartford Business Journal 2025 Charity Event Guide is the annual resource publication highlighting the top charity events in 2025.
Hartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
Delivering vital marketplace content and context to senior decision-makers throughout Connecticut ...
All Year Long!
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments